In a research note issued to investors, Brian Tanquilut at Jefferies Reiterated their Buy rating on Acadia Healthcare Company Inc (NASDAQ:ACHC). The analyst placed a $88.00 price target on the stock which indicates a 25.68% upside to the last closing price. In the year following Brian’s ratings, the stocks covered yield an average return of 11.7% according to TipRanks.com. In the past year 35 out of 49 recommendations or 71% were successful.
In looking at the consensus numbers, the sell-side analysts covering the stock have a mean target price of $78.6 for Acadia Healthcare Company, Inc. (NASDAQ:ACHC). This number is the mean estimate from the 10 research brokerages that recently issued reports on the firm.
According to Wall Street, Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is expected to report earnings per share for the current fiscal quarter of $0.53. This is the consensus mean estimate based on the individual covering sell-side analysts’ reported numbers. The company last reported earnings for the period ending on 2015-03-31 of $0.43.
The average recommendation is the arithmetical average of the individual analyst ratings contributed by sell-side research to produce a Consensus Analyst Rating for each stock. On a scale of 1 to 5 where 1 represents a Strong Buy and 5 represents a Strong Sell, has the equity is ranked 1.1 based on 10 broker recommendations. Of the 10 analyst estimates, the most bullish sees the stock reaching $88 within the next 12 months while the most bearish analyst sees the stock at $65 within the year.
Taking a look at the long term growth prospects of the company, sell-side analysts have a consensus mean earnings per share estimate for the current year of $2.29. The high end estimate for this time frame is $2.42 with the low being $2.15. In looking at the next three to five years, the long term earnings per share estimate growth rate for the company is 21.97%, based on 4 analysts providing projections.
Acadia Healthcare Company, Inc. is a provider of inpatient behavioral healthcare services in the United States. The Company’s principal business is to develop and operate inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral health services in the United States. As of March 1, 2011, the Company operated a total of 32 behavioral healthcare inpatient and outpatient facilities, with over 2,100 licensed beds, in 19 states. In September 2012, it acquired Timberline Knolls, a 122-bed inpatient behavioral healthcare facility located near Chicago in Lemont, Illinois. In November 2012, the Company purchased Park Royal Hospital. On January 1, 2013, the Company acquired Greenleaf Center. In May 2013, the Company merged with Capestrano Investment Co. In May 2013, it merged with Ten Broeck Tampa Inc.